Biopharma News

Jul 19, 2018
By BioPharm International Editors
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
Jul 18, 2018
By BioPharm International Editors
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
Jul 18, 2018
By BioPharm International Editors
AbbVie will grant Mylan license to launch a biosimilar to AbbVie’s Humira.
Jul 17, 2018
By BioPharm International Editors
Moderna’s new manufacturing plant in Norwood, MA gives the company capacity for preclinical and Phase I and II clinical manufacturing for its mRNA development candidates, including personalized cancer vaccines.
Jul 16, 2018
By BioPharm International Editors
Otsuka Pharmaceutical will acquire Visterra, a clinical-stage biotechnology company focused on developing antibody-based therapies, for approximately $430 million.
Jul 11, 2018
By BioPharm International Editors
Pfizer creates separate business units for innovator medicines, generic drugs, and consumer products.
Jul 11, 2018
By BioPharm International Editors
The company has received clearance from the United States Federal Trade Commission for the proposed acquisition of Shire, a deal valued at $62 billion.
Jul 11, 2018
By BioPharm International Editors
Teva Pharmaceuticals USA will move its US headquarters to Parsippany-Troy Hills, NJ.
Jul 09, 2018
By BioPharm International Editors
The company opened its new global headquarters in Japan.
Jul 06, 2018
By BioPharm International Editors
Sanofi will open a R&D operations hub in Chengdu, Sichuan province, China, with a focus on digitalization and big data analysis.
native1_300x100
lorem ipsum